SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-24-006623
Filing Date
2024-09-24
Accepted
2024-09-24 16:05:33
Documents
68
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q FOR JUNE 2024 actuate_i10q-063024.htm   iXBRL 10-Q 1420301
2 NON-EMPLOYEE DIRECTOR COMPENSATION POLICY actuate_ex1001.htm EX-10.1 19226
3 CERTIFICATION actuate_ex3101.htm EX-31.1 7490
4 CERTIFICATION actuate_ex3102.htm EX-31.2 7470
5 CERTIFICATION actuate_ex3201.htm EX-32.1 6071
  Complete submission text file 0001683168-24-006623.txt   5736312

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE actu-20240630.xsd EX-101.SCH 38481
7 XBRL CALCULATION FILE actu-20240630_cal.xml EX-101.CAL 42270
8 XBRL DEFINITION FILE actu-20240630_def.xml EX-101.DEF 180160
9 XBRL LABEL FILE actu-20240630_lab.xml EX-101.LAB 330133
10 XBRL PRESENTATION FILE actu-20240630_pre.xml EX-101.PRE 302651
70 EXTRACTED XBRL INSTANCE DOCUMENT actuate_i10q-063024_htm.xml XML 738572
Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 847-986-4190
ACTUATE THERAPEUTICS, INC. (Filer) CIK: 0001652935 (see all company filings)

IRS No.: 473044785 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42139 | Film No.: 241320241
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)